Measuring great saphenous vein (GSV) diameter is standard in pre-interventional assessment of varicose disorders, but has never been properly validated. This work assessed the relative value of measuring GSV diameter at the most often used sites: the sapheno-femoral junction and the proximal thigh. We found a better correlation of the latter with reflux and both higher sensitivity and specificity for clinical disease severity. A conversion factor was calculated and used to revise published data. The conversion factor enabled comparison of venous disease severity of patients included in 10 interventional series with preoperative GSV measurements taken either at the sapheno-femoral junction or at the proximal thigh.
Varicose disease affects one third of the population 1 and has an impact on morbidity, quality of life and health costs. The great saphenous vein (GSV) is involved in the majority of cases. Symptoms include distressing feelings of swelling and heaviness and frank pain. Objective findings are meandering and dilated superficial veins, oedema, dermatitis, dermatosclerosis and skin ulceration. These manifestations are the consequence of long-standing volume overload and hypertension in cutaneous veins caused by wall distension, valve incompetence, blood flow abnormality and secondary phenomena such as allergy and inflammation.
Treatment is directed towards abolition of venous reflux. For decades, this has been accomplished by ligation of the GSV at its junction with the common femoral vein (CFV) and vein stripping, first of the entire GSV, later limited to its refluxing part. In the last decades, alternative options became available, such as haemodynamic surgery, 2e5 endovenous thermal ablation 6e8 and foam sclerotherapy. 9 Duplex ultrasound is widely employed to guide these interventions.
Comparison of treatment modalities requires exact documentation of the clinical, anatomical and functional situation prior to whichever treatment is given. 10, 11 Reflux and GSV diameter measurements may serve as surrogate parameters for disease severity and provide criteria for planning interventions and monitoring outcome. GSV diameters have been assessed at various sites with different techniques: upright or recumbent patient position, crosssectional or longitudinal imaging, and various sites of interest. Measurements are regularly made at the saphenofemoral junction (SFJ), above or below the pre-terminal valve, and anywhere at the thigh. A consensus-based manual recommends two sites where GSV diameters should be measured, 3 cm below the SFJ and mid-thigh, 10 while earlier studies used a site 15 cm below the SFJ. 12, 13 Thus far, neither the clinical relevance of these measurements nor the relative significance of the site of measurement has been clarified.
The aim of this study was to investigate a possible correlation of GSV diameters measured at the SFJ and the proximal thigh (PT) with the importance of the venous disorder and to establish a conversion factor usable to compare published data.
METHODS
An anatomical and functional survey of the GSV was undertaken in consecutive outpatients who consulted with the suspicion or presence of a primary venous disorder. It was a practitioner-initiated study performed in a vein clinic in Germany between October and December 2009. The protocol was accepted by the Ethics Committee of the State Medical Chamber of Lower Saxony, Germany.
The criterion for patient inclusion was the presence of a leg with isolated GSV reflux and varices limited to its territory. Eligible legs were included irrespective of the findings on the other leg. Exclusion criteria were previous treatment of the index leg for varicose veins and its complications, deep venous reflux, acute disorders (thrombosis, phlebitis and cellulitis) and lymphoedema. Candidates with known pregnancy, age below 18 years and any concomitant overt health problem were excluded.
Colour-coded duplex ultrasound examinations were performed by a single investigator with a General Electric Logic 5 colour-coded duplex scanner fitted with a 7.5-MHz linear probe. 10, 14 The GSV was examined in the standing position applying toe movements, manual compression and decompression as well as Valsalva manoeuvres to assess orthograde flow and reflux. Reflux lasting longer than 1 s was considered pathologic. 15 The detailed anatomical and functional ultrasound study was the basis for selection and sorting of legs. Included were legs with GSV reflux beginning at the terminal or the preterminal valve and escaping through a mid-thigh branch vein (GSV incompetence above knee only e group II (As 2 )) or escaping through a lower leg branch vein (GSV incompetence above and below knee e group III (As 2,3 )). No assessment was made of dilated distal branch veins and eventually incompetent perforator veins. Excluded were legs with reflux through the terminal and pre-terminal valve escaping through the anterior or the posterior accessory veins with competent valves in the GSV just distal to the groin. Further were excluded legs with no reflux in the GSV trunk at the PT but with reflux in the distal portion, as seen in cases with incompetence of thigh perforators, reflux from the short saphenous vein through a Giacomini anastomosis or incompetence of superficial branches joining the GSV at mid thigh. Legs with no GSV reflux but meeting the other inclusion and exclusion criteria were recruited as controls (group I).
Clinical findings were documented according to the highest CEAP (Clinical, etiologic, anatomic and pathophysiologic) class. Legs could range from teleangiectasies (C1) to healed venous ulcers (C5). In all cases, the aetiology was primary (Ep) and pathophysiology reflux (Pr). The anatomy was varicose GSV trunk with (As 2AE3þ5 ) or without (A 2þ3 ) branch varices. Findings in control legs could be C0, C0s, C1, C2 (Ep, As 5 and Pr) and C3.
Vein diameters were measured holding the probe transversely with no pressure. Duplicate measurements were taken at two sites: at the SFJ distal to the terminal valve and 15 cm below the junction. This site, chosen by CHIVA (Conservative ambulatory haemodynamic management of VAricose veins) Group members, shows parallel walls of the GSV and is located above the junction of the most proximal branch veins. 12, 13 Photoplethysmography was performed with the ELCAT Vasoquant Ò instrument. Muscle pump activity is described as blanching of the skin, in %. Refilling time to 100% is given in seconds.
Power analysis was based on data of an unpublished pilot study, which revealed a Pearson's r ¼ 0.8 for the comparison of GSV diameters measured simultaneously at the SFJ and PT. In this study, we intended to differentiate between three groups. Power analysis asked for inclusion of 46 participants per group to discriminate between Pearson's r of 0.7 and 0.9 with a statistical power of 80%. Therefore, a study was set up with 60 consecutive patients per group. Subject allocation was planned to be halted when 60 control legs and 120 legs of groups II and III were included.
Data analysis was performed with Statistical Package for the Social Sciences (SPSS) 13.0. To compare subgroups, chisquared tests for non-parametric and t-tests or Analysis of Variance (ANOVA) for parametric data were applied. Pearson correlations were calculated to compare vein diameters with other parameters. A p < 0.05 was considered significant. Specificity and sensitivity were calculated taking the diameter values of subjects without reflux as threshold values (mean, meanþ1SD and mean þ 2SD). The discriminating power of diameters measured at the SFJ and the PT for reflux and C-classes 2e5 was estimated by calculating Area Under the Receiver Operating Characteristic (AUROC) curves and 95% confidence intervals (CIs).
A conversion factor was established, which allowed comparison of the vein diameter measured at the SFJ with the diameter determined at the PT. A Pearson's r ! 0.7 was considered to be high enough to permit the use of a linear regression model without entering a constant and to calculate a conversion factor between the two variables
The conversion factor was applied to published data. Selection of studies was begun with a systematic literature search in Medline, gathering studies on the treatment of GSV insufficiency with stripping, endoluminal ablation by laser or radiofrequency, foam sclerotherapy, CHIVA or incompetent sAphenouS Vein preservAtion with phLebectomy (ASVAL) published between 2000 and 2010. Eligible studies had to state inclusion and exclusion criteria similar to the ones used in this survey and to provide pre-interventional data on reflux and GSV diameters measured at the SFJ or at the PT in a standing position. Studies applying diameter limits for inclusion were excluded. Studies that presented pre-interventional data on various occasions were included only once. Authors were contacted for clarification if this was not clear from the publication. The factor was used to mutually convert data obtained at either point in order to make the studies comparable.
RESULTS
We screened 844 legs and included 182 legs in the survey (Fig. 1 ). Sixty legs with no GSV reflux and no exclusion criteria served as controls (group I, As 0 AE 1 AE 5 , Pr). Truncal GSV reflux was found in 122 legs. Reflux was limited to the thigh in 51 legs (above knee reflux, group II, As, Pr 2 AE 5 ) and extended to the lower leg in 71 legs (above and below knee reflux, group III, As 2 þ 3 AE 5 , Pr).
Demography of patients was equal in the three groups with the exception of weight and body mass index (BMI), which was slightly higher in patients of group II compared to group III (Table 1) .
Clinical findings of a venous disorder were absent (C0) in 45% of patients in group I. Teleangiectases (C1) were found in 22%, branch varices (C2) in 12% and oedema (C3) in 22%, the latter associated with branch varices and/or obesity and lipoedema. In groups II and III, absence of any sign of a venous disorder (C0) was found in 3% and teleangiectasis only (C1) was observed in 12%. Branch varices (C2) were found in 46%, oedema (C3) in 25% and skin changes (C4e5) in 15%.
Venous function tests were normal in legs with no GSV reflux (group I): muscle pump function 3.6% (AE2.5) and refilling time 29.0 s (AE13.0). In patients with GSV reflux (groups II and III), muscle pump function was normal (4.1 AE 2.4%). Refilling time was slightly shortened to 23.9 s (AE11.6) as compared with group I (p < 0.05).
GSV diameters in all groups, measured at both sites, were not related with patients' age and sex or calf muscle-pump function. Modest correlations were found with body weight in each group (Pearson's r ¼ 0.30e0.44, p < 0.01) and BMI (Pearson's r ¼ 0.25e0.38, p < 0.01) but not with height. GSV diameters in controls (group I) measured 7.5 mm (AE1.8) at the SFJ and 3.7 mm (AE0.9) at the PT (Table 2 ). In patients with GSV reflux (groups II and III), they measured 10.9 mm (AE3.9) at the SFJ and 6.3 mm (AE1.9) at the PT, respectively. Vein diameters were larger in the presence of reflux, compared with its absence, by an average of 3.4 mm at the SFJ (p < 0.001) and 2.6 mm at the PT (p < 0.001). No difference in diameters was found between group II (10.5 mm AE 3.2 at the SFJ and 6.2 mm AE 1.7 at the PT) and group III (11.2 mm AE 4.3 at the SFJ and 5.9 mm AE 2.1 at the PT, see Table 2 ). Thus, the degree of vein dilatation was independent of the length of reflux above knee only versus above and below knee.
GSV diameters were assessed with regard to their value to predict reflux and clinical disease class (Table 3 and Fig. 2 ). The proportion of vein diameters smaller than the mean values of group I patients and of those positioned above the 2 SD margins were calculated.
A GSV diameter above the 2 SD margin of group I legs was found in 2% in group I at either point of measurement. In groups II and III, a significantly different prevalence was observed when measurements made at the SFJ and PT, respectively. The 2 SD margin was exceeded by 43% of patients when measured at the SFJ and by 62% when measured at the PT. Sensitivity and specificity are calculated for thresholds at the mean, 1 SD and 2 SD above the mean diameters of the control group.
Clinical disease class was also better predicted by diameter assessment at the PT than the SFJ level. Of legs with C 0e1 , 2% exceeded the 2 SD margins at the SFJ and 4% at the PT. Of legs with C 2e5 , 49% exceeded the limit when diameters were measured at the SFJ and 59% when measured at the PT.
AUROC curves were used to assess the relative performance of the two sites of measurement (Fig. 3) . The areas under the curve for the prediction of GSV reflux were significantly larger when measured at the PT (SFJ: AUROC ¼ 0.786, 95% CI ¼ 0.064; femoral AUROC ¼ 0.907, 95% CI ¼ 0.041). The difference was not significant for the prediction of C-class 2e5 (SFJ: AUROC ¼ 0.782, 95% CI ¼ 0.065; femoral AUROC ¼ 0.839, 95% CI ¼ 0.056).
A GSV diameter of <7.5 mm at the SFJ was associated with reflux in 20%, C 2e5 disease in 21% and the combined elements in 15%, respectively. A PT diameter of <3.7 mm was associated with reflux in 3%, C 2e5 disease in 9% and the combined elements in 2%.
Based on linear regression analysis, a mathematical formula was developed to mutually convert measurements taken at the SFJ and the PT. The correlation factors were Pearson's r ¼ 0.44 for legs in group I and r ¼ 0.77 for legs in groups II and III. Thus, we limited calculations to groups II and III. The formulae are shown in the frame.
The conversion factors were applied to published data ( Table 4 ). The literature search had identified 32 studies providing pre-treatment data on GSV diameters assessed in patients evaluated for the treatment of varicose disease of the GSV. Eight publications, including 1.856 patients, fulfilled our predefined requirements. Two trials presented a single patient group and six trials compared surgical techniques with two patient groups, which allowed evaluating 14 cohorts. In six trials (10 cohorts) including 1268 patients diameters were measured at the SFJ 16e21 . In two studies (four cohorts) including 588 patients measurements were taken at the PT. 12, 13 As compared with our patients with reflux, average GSV diameters were smaller in eight and larger in six cohorts. In six cohorts, the average diameter was below the 1SD margin of our patients with reflux and in one cohort it was in the range of our control population.
DISCUSSION
Comparison of treatment modalities requires exact documentation of the clinical, anatomical and functional situation in each patient using standardised and validated techniques. However, even the recommendations of the Union Internationale de Phlébologie (UIP) 10 regarding measurement of GSV diameter at different sites lack proper validation. Until now no effort was undertaken to show if different measurement points correlate with each other Table 3 . Sensitivity and specificity for reflux and clinical disease class of sites of diameter measurement. Percentage of diameters below and above mean, mean þ 1SD, and mean þ 2SD of the GSV diameters measured at the SFJ and PT in group I. Specificity and sensitivity between the absence (group I) and presence of reflux (group II & III legs), and no or minor (C0-1) and important (C2-5) venous disease. and whether one or the other site allows better prediction of the clinical situation.
We took measurements at the SFJ as proposed by the UIP and compared it with measurements at the PT as used and published by the CHIVA group because no data on the midthigh point have been published until 2010.
Diameter measurement at the PT seems to have some advantages as compared with measurement at the SFJ, which is a landmark easily identified with ultrasound. While GSV reflux in the groin is readily identified measurement of vein diameter right there is challenging for several reasons. The curvature of the inguinal GSV renders adjustment of the ultrasound probe exactly perpendicular to the vein axis difficult. Further, the shape of the vein is influenced by joining epigastric, pudendal and accessory veins and eventual aneurysmatic dilatations caused by deep venous refluxes. Thus, diameter assessment in the groin appears less reliable.
The PT site 15 cm below the SFJ is located in the truncal portion of GSV where the vein is cylindrical and largely devoid of joining branches. The site is also well accessible and diameter measurements can be taken reliably.
In our experience, nearly a third of patients with reflux in GSV limited to above knee have a sufficient GSV at mid thigh, because the refluxing branch has left the GSV more proximally. Thus, the diameter of the refluxing part of the GSV would be missed if measurements were taken at mid thigh.
The CHIVA Group measures diameters 15 cm distal to the SFJ 12,13 because the PT site allows outcome assessment, as their treatment strategy leaves the GSV trunk in situ even when crossectomy is performed.
A further advantage emerges from our data. Measurement at the PT as compared to measurement at the SFJ demonstrated higher accuracy and both higher sensitivity and specificity for venous disease class as well as for prediction of reflux (Table 3) . Thus, diameter measurement at the PT may develop as a surrogate parameter for specific clinical situations.
Our data revealed a debatable finding: GSV diameter, venous haemodynamics (refilling times in photoplethysmography (PPG)) and clinical disease class did not differ whether reflux was above knee only or above and below knee.The finding is in disagreement with the understanding that the length of reflux in the GSV would have an influence on disease severity. 18, 22, 23 The correlation between the two measurement sites permitted calculation of a conversion factor used to review selected publications. It disclosed a wide range of diameters in patients worked up for interventions with different techniques (Table 4 ). The data suggest that some studies included patients with minor disease. The same may be true for a recent study that found no correlation between GSV diameter and quality of life. 24 The reported diameters were within the limits of the control subjects of this study.
Diameter assessment at the PT seems suitable for stratification of patients allocated to future interventional trials as well as for outcome evaluation. With more data available it may also become an argument in the discussion of treatment options with patients, which is not the case at the moment. 
